Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Major funding boost for US FDA's devices programme

This article was originally published in RAJ Devices

Executive Summary

The US Food and Drug Administration will receive a record $3.2 billion towards salaries and expenses in fiscal year 2010 under an appropriations bill signed into law by the US president1.

You may also be interested in...



EMA Commissions Research On Real-World Monitoring Of COVID-19 Vaccines

The European Medicines Agency is taking steps to establish infrastructure for monitoring COVID-19 vaccines whenever they reach the European market.

WHO ‘Showed Leadership’ In Dealing With COVID-19, Says Interim Inquiry

An interim independent assessment of the WHO’s response to the COVID-19 pandemic has supported the organization’s work. But will be it enough to convince critics as the WHO faces the threat of permanently losing funds from its biggest donor, the US?

WHO ‘Showed Leadership’ In Dealing With COVID-19, Says Interim Inquiry

An interim independent assessment of the WHO’s response to the COVID-19 pandemic has supported the organization’s work. But will be it enough to convince critics as the WHO faces the threat of permanently losing funds from its biggest donor, the US?

UsernamePublicRestriction

Register

LL1132458

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel